Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Current assets:    
Cash $ 518,905 $ 25,000
Prepaid expenses 73,865
Total current assets 592,770 25,000
Investments held in Trust Account 174,230,428
Total Assets 174,823,198 25,000
Current liabilities:    
Accounts payable 153,601
Accrued expenses 29,500 1,000
Accrued expenses - related party 53,333
Franchise tax payable 97,200
Total current liabilities 333,634 1,000
Warrant liabilities 7,973,250
Total Liabilities 8,306,884 1,000
Commitments and Contingencies
Common stock subject to possible redemption, $0.0001 par value; 17,250,000 and 0 shares issued and outstanding at redemption value at December 31, 2021 and December 31, 2020, respectively 174,225,000
Stockholders’ (Deficit) Equity    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; 0 shares issued and outstanding at December 31, 2021 and December 31, 2020
Common stock, $0.0001 par value; 200,000,000 shares authorized; 4,312,500 shares issued and outstanding (excluding 17,250,000 and 0 shares subject to possible redemption) at December 31, 2021 and December 31, 2020 431 431
Additional paid-in capital 24,569
Accumulated deficit (7,709,117) (1,000)
Total Stockholders’ (Deficit) Equity (7,708,686) 24,000
TOTAL LIABILITIES, COMMON STOCK SUBJECT TO POSSIIBLE REDEMPTION AND STOCKHOLDERS’ (DEFICIT) EQUITY $ 174,823,198 $ 25,000